Workflow
退市风险
icon
Search documents
21个跌停板!603388,触及强制退市!
中国基金报· 2025-11-10 12:15
Core Viewpoint - *ST Yuancheng has received a notice from the Shanghai Stock Exchange regarding the potential termination of its stock listing due to its market capitalization falling below 500 million yuan for 20 consecutive trading days [2][3]. Group 1: Stock Listing Status - As of November 10, 2025, *ST Yuancheng's stock has been below the 500 million yuan threshold for 20 consecutive trading days, triggering the termination listing condition according to the Shanghai Stock Exchange's regulations [3]. - Following the announcement, *ST Yuancheng's stock price dropped to 0.58 yuan per share, with a market capitalization of 190 million yuan after 21 consecutive days of trading at the limit down [3][4]. Group 2: Regulatory Actions - The company received a regulatory letter from the Shanghai Stock Exchange requiring it to disclose risks and manage the termination of its stock listing appropriately [5]. - Earlier, *ST Yuancheng was issued an administrative penalty notice by the China Securities Regulatory Commission for false disclosures in its annual reports from 2020 to 2022, with a proposed fine of 37.45 million yuan [7]. Group 3: Financial Performance - *ST Yuancheng has reported losses for three consecutive years from 2022 to 2024, totaling over 500 million yuan in net losses [7]. - In the first three quarters of the current year, the company achieved a revenue of 102 million yuan, a slight increase of 0.1% year-on-year, but incurred a net loss attributable to shareholders of 143 million yuan [7].
股市必读:11月7日*ST元成发生1笔大宗交易 成交金额18.32万元
Sou Hu Cai Jing· 2025-11-09 19:29
Summary of Key Points Core Viewpoint - *ST Yuan Cheng (603388) is facing significant financial distress, with potential risks of forced delisting due to continuous low market capitalization and stock price below regulatory thresholds [3][4]. Trading Information - On November 7, 2025, *ST Yuan Cheng closed at 0.61 yuan, down 4.69%, with a turnover rate of 0.54% and a trading volume of 17,400 shares, amounting to a total transaction value of 1.064 million yuan [1]. - The net outflow of main funds was 665,200 yuan, accounting for 62.52% of the total transaction value, while retail investors saw a net inflow of 459,500 yuan, representing 43.19% of the total [1][4]. - A block trade occurred on November 7, with a transaction amount of 183,200 yuan [2][4]. Company Announcements - The total market capitalization of Yuan Cheng Environment Co., Ltd. was 199 million yuan as of November 7, 2025, having been below 500 million yuan for 19 consecutive trading days, which could lead to forced delisting if it continues [3][4]. - The stock price has been below 1 yuan for 10 consecutive trading days, which also risks triggering delisting standards [3][4]. - The company received a notice from the China Securities Regulatory Commission regarding administrative penalties due to false records in annual reports from 2020 to 2022, which may result in significant legal consequences and forced delisting [3][4]. - The net profit for the first half of 2025 was reported at -126.795 million yuan, indicating ongoing uncertainty in the company's ability to continue operations [3].
连续20个“一字”板跌停!*ST元成锁定退市,市值仅剩2亿元,曾连续3年财务造假,时任董事长被罚2800万元
Sou Hu Cai Jing· 2025-11-09 04:37
Core Viewpoint - *ST Yuancheng is facing potential delisting due to its market capitalization falling below 500 million yuan and stock price below 1 yuan per share, with a current stock price of 0.61 yuan and a total market value of only 199 million yuan after 20 consecutive trading days of a "limit down" [2][6]. Financial Performance - In the first three quarters of this year, *ST Yuancheng reported revenue of 102 million yuan, a slight increase of 0.1% year-on-year, but continued to incur losses with a net profit attributable to shareholders of -143 million yuan [8]. - For the first half of the year, the company had an operating income of 82.34 million yuan and a net profit of -126.80 million yuan, indicating ongoing financial distress [7]. Regulatory Issues - The company has been issued a notice of administrative penalty by the China Securities Regulatory Commission (CSRC) for false reporting in its annual reports from 2020 to 2022, which included inflated project costs and revenues [8][9]. - The CSRC's findings may lead to a significant violation that could trigger mandatory delisting under stock listing rules, with potential penalties including fines totaling 37.45 million yuan for the company and 42 million yuan for responsible individuals, including a 28 million yuan fine for the actual controller [9]. Future Risks - *ST Yuancheng has been under a risk warning for its stock since October 13, 2025, and if it fails to meet the delisting criteria after the 2025 annual report, it may face termination of its listing [9].
股价0.61元、市值仅剩2亿元,浙江杭州一上市公司锁定退市!曾连续3年财务造假被重罚,实控人被罚2800万元
Mei Ri Jing Ji Xin Wen· 2025-11-09 01:31
Core Viewpoint - *ST Yuancheng is facing multiple delisting risks due to its market capitalization falling below 500 million yuan and stock price dropping below 1 yuan, which could lead to forced delisting from the stock exchange [1][2][3] Financial Performance - In the first three quarters of the year, the company reported revenue of 102 million yuan and a net loss attributable to shareholders of 143 million yuan [7] - For the third quarter alone, revenue was 20.14 million yuan, a year-on-year decrease of 54.70%, with a net loss of 16.34 million yuan [7] - Revenue figures for the years 2022 to 2024 were 294 million yuan, 274 million yuan, and 146 million yuan respectively, with net losses of 65.48 million yuan, 162 million yuan, and 325 million yuan [7] Delisting Risks - As of November 7, the company's total market capitalization was 199 million yuan, having been below 500 million yuan for 19 consecutive trading days, which will trigger forced delisting after 20 days [2][3] - The stock price closed at 0.61 yuan on November 7, having been below 1 yuan for 10 consecutive trading days, which also contributes to the delisting risk [3] - The company has received multiple warnings regarding delisting, including a notice from the China Securities Regulatory Commission about significant violations leading to potential forced delisting [9][10] Regulatory Issues - The company has been found to have false records in its annual reports from 2020 to 2022, which included inflated project costs and revenues [9][10] - The company is facing penalties totaling 37.45 million yuan and potential market bans for key personnel due to these violations [10] Operational Challenges - The company has been experiencing a continuous decline in business performance and has been in a state of loss for several years [8] - There are concerns regarding the company's ability to continue as a going concern, with issues such as overdue fundraising and liquidity risks [10]
603388,锁定退市!
中国基金报· 2025-11-08 16:05
Core Viewpoint - *ST Yuancheng (603388) is facing imminent delisting risks due to multiple violations and financial issues, with only one trading day left before potential forced delisting [2][6]. Group 1: Delisting Risks - The company has triggered multiple delisting risks, including a trading-based forced delisting due to a market capitalization below 500 million yuan for 20 consecutive trading days [3][6]. - As of November 7, 2025, the company's total market capitalization was 199 million yuan, and the closing price was 0.61 yuan, which has been below 1 yuan for 10 consecutive trading days [3][7]. - The company will face suspension of trading and a delisting decision from the exchange after November 10, 2025, due to these violations [6][7]. Group 2: Financial Violations - The company received a notice from the China Securities Regulatory Commission (CSRC) regarding administrative penalties for false reporting in annual reports from 2020 to 2022, including inflated revenues and profits [7][8]. - The company has been under risk warning since October 13, 2025, due to these violations, which may lead to a major illegal forced delisting [7][8]. Group 3: Financial Performance - For the third quarter of 2025, the company reported revenues of 102.48 million yuan and a net loss of 143.14 million yuan attributable to shareholders [8]. - The company faces uncertainties regarding its ability to continue operations, with overdue fundraising, stock pledges, freezes, liquidations, and other liquidity risks [8].
603388,锁定退市!
Zheng Quan Shi Bao· 2025-11-08 14:40
Core Viewpoint - *ST Yuancheng is facing imminent delisting risks due to its market capitalization falling below 500 million yuan and stock price remaining below 1 yuan for consecutive trading days [1][2][4]. Group 1: Delisting Risks - As of November 7, the total market capitalization of *ST Yuancheng was 199 million yuan, having been below 500 million yuan for 19 consecutive trading days [2][4]. - The stock price closed at 0.61 yuan on November 7, remaining below 1 yuan for 10 consecutive trading days [2][4]. - The company is set to face trading-type mandatory delisting after November 10 due to these conditions [4]. Group 2: Regulatory Actions - On October 10, the company received a notice from the China Securities Regulatory Commission regarding administrative penalties for false reporting in its annual reports from 2020 to 2022 [5]. - The company is at risk of being subjected to mandatory delisting due to significant violations of regulations, including fabricating major false content in its non-public stock issuance documents [5]. Group 3: Financial Performance - For the third quarter of 2025, the company reported revenues of 102.48 million yuan and a net loss attributable to shareholders of 143.14 million yuan [6]. - The company faces uncertainties regarding its ability to continue operations, overdue fundraising, and multiple liquidity risks [6].
300391 被证监会立案!涉嫌财务造假 或强制退市
Zhong Guo Ji Jin Bao· 2025-11-07 15:01
Core Viewpoint - *ST Changyao is facing a critical survival challenge due to the China Securities Regulatory Commission's investigation, the looming risk of delisting, and difficulties in its pre-restructuring process [2][3][4] Financial Situation - As of December 31, 2024, *ST Changyao reported a negative net asset of -433 million yuan and an accumulated loss of -1.59 billion yuan, with a net profit of -628 million yuan for the year [4] - The company's revenue has drastically declined from 1.615 billion yuan in 2022 to 1.198 billion yuan in 2023, and further down to only 112 million yuan in 2024 [5] - For the first three quarters of 2025, *ST Changyao's revenue increased by 4.4% year-on-year to 105 million yuan, but the net profit decreased by 15.89% to -210 million yuan [5] Delisting Risk - The company is under significant threat of mandatory delisting due to its negative net asset situation and the potential for administrative penalties from the CSRC [2][3][6] - If *ST Changyao fails to improve its financial performance in Q4 2025, it will trigger the delisting clause related to negative net assets [6] Restructuring Challenges - Prior to the CSRC investigation, *ST Changyao was already struggling with debt, leading to the initiation of pre-restructuring by the Hubei Province Shiyan Intermediate People's Court on January 20, 2025 [7] - The court has extended the pre-restructuring period until January 20, 2026, indicating slow progress in the restructuring efforts [8] - The company has warned of the uncertainty surrounding its ability to enter formal restructuring and the risk of bankruptcy if restructuring fails [9] Legal and Financial Liabilities - Due to overdue debts, several creditors have initiated lawsuits against *ST Changyao, resulting in the freezing of numerous bank accounts and asset seizures [11] - As of October 20, 2025, the company had significant interest-bearing liabilities totaling 1.106 billion yuan, with 390 million yuan overdue [11] - The company is involved in 140 legal cases with a total amount in dispute of 1.878 billion yuan, which is 434% of its latest audited net assets [11] Market Performance - As of November 7, 2025, *ST Changyao's stock price was 3.45 yuan per share, with a total market capitalization of only 1.209 billion yuan [13]
300391,被证监会立案!涉嫌财务造假,或强制退市
中国基金报· 2025-11-07 14:54
Core Viewpoint - *ST Changyao is facing a critical situation due to a formal investigation by the China Securities Regulatory Commission (CSRC) for suspected financial data falsification, which may lead to mandatory delisting risks and ongoing pre-restructuring challenges [2][4]. Financial Risks - The company has been under the shadow of delisting due to severe financial issues, with a negative net asset value of -433 million yuan as of December 31, 2024, and an accumulated loss of -1.59 billion yuan [7]. - Revenue has drastically declined from 1.615 billion yuan in 2022 to 1.198 billion yuan in 2023, with projections of only 112 million yuan for 2024 [8]. - For the first three quarters of 2025, the company reported a 4.4% year-on-year revenue increase to 105 million yuan, but net profit decreased by 15.89% to -210 million yuan [8]. Delisting Risks - If *ST Changyao fails to improve its financial performance in Q4 2025, it will trigger the delisting clause due to negative audited net assets [9]. - The company has been under a delisting risk warning since April 22, 2025, following a negative net asset report for the 2024 fiscal year [6]. Pre-restructuring Challenges - Prior to the CSRC investigation, *ST Changyao was already struggling with debt, leading to a pre-restructuring process initiated by the Hubei Province Shiyan Intermediate People's Court on January 20, 2025 [11]. - The court has extended the pre-restructuring period until January 20, 2026, indicating difficulties in the restructuring process [11]. - The company has warned of the risk of bankruptcy if the restructuring fails, despite several subsidiaries already undergoing restructuring [13][14]. Legal and Financial Liabilities - The company faces significant legal challenges, with 140 lawsuits involving a total of 1.878 billion yuan, which is 434% of its latest audited net assets [15]. - As of October 20, 2025, *ST Changyao reported total interest-bearing liabilities of 1.106 billion yuan, with 390 million yuan overdue [15]. - A substantial number of bank accounts (67.7%) have been frozen due to overdue debts, severely impacting the company's financial operations [15][16]. Market Performance - As of November 7, 2025, *ST Changyao's stock price was 3.45 yuan per share, with a total market capitalization of 1.209 billion yuan [17].
ST中迪股价严重异常波动 提示多重投资风险
Xi Niu Cai Jing· 2025-11-07 13:50
Core Viewpoint - ST Zhongdi's stock experienced significant abnormal fluctuations, with a cumulative increase of 16.11% over three consecutive trading days from October 29 to 31, raising concerns about its underlying fundamentals [1][2]. Group 1: Stock Performance - The stock price increased by over 71.39% from October 16 to 31, which is significantly disconnected from ST Zhongdi's fundamental performance [1]. - The stock has shown abnormal fluctuations in four out of the last ten trading days, triggering severe abnormal fluctuation standards [1]. Group 2: Financial Health - ST Zhongdi has reported negative net profits for the past three years, indicating substantial uncertainty regarding its ongoing operational capability [1]. - For the third quarter of 2025, the company reported a significant revenue decline of 74.30%, resulting in a net loss of 66.4984 million [1]. Group 3: Ownership and Control - The controlling shareholder's 71.1448 million shares (23.77% of total shares) were auctioned for 255 million yuan on October 17, leading to uncertainties regarding the company's control [1]. Group 4: Valuation Metrics - ST Zhongdi's price-to-book ratio stands at 35.88 times, which is significantly higher than the industry average of 0.90 times for the real estate sector [1].
*ST长药涉嫌财务造假被立案 多重危机下退市风险高企
Zheng Quan Ri Bao Wang· 2025-11-07 13:25
11月7日,长江医药控股股份有限公司(以下简称"*ST长药(300391)")公告称,公司收到中国证监会下 发的《立案告知书》,因公司涉嫌定期报告等财务数据虚假记载,根据《中华人民共和国证券法》《中 华人民共和国行政处罚法》等法律法规,中国证监会决定对公司立案。 公告显示,若后续经中国证监会行政处罚认定的事实,触及《深圳证券交易所创业板股票上市规则》规 定的重大违法强制退市情形,*ST长药股票将被实施重大违法强制退市。 而回溯公司过往公告,诸多风险隐患早已显现,叠加此次财务真实性相关的立案调查,*ST长药的经营 与资本层面均已陷入多重危机,广大投资者应充分评估相关风险。 在经营陷入困境的同时,*ST长药的内控漏洞也不断暴露,多次发生违规操作且未履行信息披露义务。 经营状况持续恶化 具体来看,在资金管理方面,截至2023年末,公司向时任董事、总经理罗明控制的企业累计违规提供财 务资助1.8亿元,该金额占公司最近一期经审计净资产的92%,尽管这笔资金在2024年通过关联方债权 债务转让等方式收回,但违规行为已严重违反规范运作要求。 此外,公司控股孙公司还曾未经审议便对外提供809.2万元的关联担保,占最近一期经审 ...